Caring for your smile from within

Welcome to the OBSESSIVE lab, where we develop and test our products.

Get a FREE V34 whitener!

Sign up with your email and participate in the weekly drawing for a V34 teeth whitening product.

Introducing the OBSESSIVE Research Center

All of our research, formulation, and product testing is conducted in-house at our Spanish headquarters, through our own OBSESSIVE Research Center.

Meet our research team

Led by Dr. Mauro Pascolutti, the OBSESSIVE research team works with renowned dentists, industry experts, and our entire community to shape the future of smile care.

Esteban Rodríguez - Director of Research and Development> </div> <div class=

Esteban Rodríguez

Director of Research and Development

Dr. Rodriguez is responsible for the development of all new OBSESSIVE formulations. Esteban holds a PhD and a Master's degree in Drug Development and was previously Chief Scientist at the Glycomics Institute of a leading university in Spain.

Alina Park - Research and Development Specialist> </div> <div class=

Alina Park

Research and Development Specialist

With a Master's degree in Pharmaceutical Sciences and over 15 years of experience in Australia and Brazil, Alina is responsible for the development of formulations that pass through the Research Center.

Elizabeth Fuentes - Specialist in Orthodontics and Dentofacial Orthopedics> </div> <div class=

Elizabeth Fuentes

Specialist in Orthodontics and Dentofacial Orthopedics

With a degree in Chemistry and over a decade of industry experience in London and the UK, Elizabeth is responsible for leading the research and development of new products that meet the highest standards of smile care.

The PAP+ clinical trial

The PAP+ clinical trial was conducted by outside dentists. Each participant completed a single ten-minute teeth whitening treatment.

100% whiter teeth

61.9% got more than 3 shades of white

0% experienced sensitivity

PAP+ clinical trial

After just one 10-minute treatment...

  • 100% of participants saw instant results.
  • 61.9% of participants improved by more than 3 shades.
  • 0% of participants experienced sensitivity.
  • Average improvement of 3.4 shades.
  • Maximum improvement of 8 shades.

About the PAP+ clinical trial

The PAP+ clinical trial was conducted by a third-party dentist at an off-site facility and included 44 individuals between the ages of 19 and 55.

Each participant completed a single ten-minute teeth whitening treatment with a "novel whitening formula" in an unbranded container.

50% of participants received a placebo, while the other 50% received the PAP+ formulation.

The trial was double-blind, meaning that neither the dentist nor the participants knew what treatment they were receiving.

Before and after treatment, participants' tooth tone and sensitivity level were assessed.

Changes in tooth shade were measured in person using the VITA Whitening Guide, and digitally via high-resolution photographs taken under controlled lighting conditions.

1 Based on a dentist-led clinical report evaluating the efficacy and safety of the OBSESSIVE PAP+ Teeth Whitening Kit after a single 10-minute treatment.

See the latest from the @obsessive.smiles lab